ADMA BIOLOGICS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
ADMA BIOLOGICS, INC. (ADMA) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$8.28 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-11.
Discontinued › Income Statement
us-gaap:ProfitLoss · last filed 2015-08-11
- 2015-06-30: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month -$8.28M.
- 2014-06-30: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month -$9.87M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month |
|---|---|
| 2015-06-30 | -$8.28M 10-Q · filed 2015-08-11 |
| 2014-06-30 | -$9.87M 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |